Literature DB >> 30730428

Evaluating the Concurrent Validity of PROMIS Physical Function in Anterior Cervical Discectomy and Fusion.

Benjamin Khechen1, Dil V Patel, Brittany E Haws, Kaitlyn L Cardinal, Jordan A Guntin, Junyoung Ahn, Kern Singh.   

Abstract

STUDY
DESIGN: This study was a retrospective cohort analysis.
OBJECTIVES: This study aims to evaluate the concurrent validity of Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) domain as compared with legacy measures of patient-reported outcomes (PROs) among patients undergoing anterior cervical discectomy and fusion (ACDF). SUMMARY OF BACKGROUND DATA: As PROMIS becomes increasingly utilized, it is important to assess its validity among procedure-specific populations.
METHODS: Patients undergoing a primary, 1-3 level ACDF were retrospectively identified from a prospectively maintained surgical registry. PROMIS PF and legacy PRO scores were obtained at preoperative, 6-week, 12-week, and 6-month postoperative visits. Legacy PROs included Neck Disability Index (NDI), Short Form-12 (SF-12) physical composite, Visual Analog Scale (VAS) neck pain, and VAS arm pain. Postoperative improvements in PROs were assessed using paired t tests. Correlations between PROMIS and legacy PROs were tested using Pearson correlation coefficient.
RESULTS: A total of 57 ACDF patients were analyzed. The mean preoperative PROMIS PF was 40.0±6.4. PROMIS PF significantly improved at 12-week and 6-month follow-up. NDI, VAS neck pain, and VAS arm pain scores demonstrated significant improvement at all postoperative time points. SF-12 scores only exhibited significant improvement at the 6-month follow-up visit. Significant correlations between PROMIS PF, NDI, and SF-12 were identified at all preoperative and postoperative time points. PROMIS PF exhibited strong correlations with VAS neck pain at postoperative time points, and a moderate correlation preoperatively.
CONCLUSIONS: Patients undergoing a primary 1-3 level ACDF experience significant improvements in PROMIS PF scores at 12-week and 6-month follow-up. Furthermore, PROMIS PF exhibits strong correlations to NDI and SF-12 at all preoperative and postoperative time points. These results suggest that PROMIS PF accurately measures PF and may be used in lieu of legacy PF instruments for patients undergoing ACDF.

Entities:  

Mesh:

Year:  2019        PMID: 30730428     DOI: 10.1097/BSD.0000000000000786

Source DB:  PubMed          Journal:  Clin Spine Surg        ISSN: 2380-0186            Impact factor:   1.876


  5 in total

1.  Recovery of Physical Function Based on Body Mass Index Following Anterior Cervical Discectomy and Fusion.

Authors:  Elliot D K Cha; Conor P Lynch; James M Parrish; Nathaniel W Jenkins; Shruthi Mohan; Cara E Geoghegan; Caroline N Jadczak; Kern Singh
Journal:  Int J Spine Surg       Date:  2021-12

2.  Correlation Between the PROMIS Pediatric Mobility Instrument and the Hospital for Special Surgery Pediatric Functional Activity Brief Scale (HSS Pedi-FABS).

Authors:  Joshua Adjei; Jonathan M Schachne; Daniel W Green; Peter D Fabricant
Journal:  HSS J       Date:  2019-12-04

3.  Validating the VR-12 Physical Function Instrument After Anterior Cervical Discectomy and Fusion with SF-12, PROMIS, and NDI.

Authors:  Nathaniel W Jenkins; James M Parrish; Michael T Nolte; Nadia M Hrynewycz; Thomas S Brundage; Kern Singh
Journal:  HSS J       Date:  2020-11-09

4.  Patient-Reported Outcomes Measurement Information System Physical Function Validation for Use in Anterior Cervical Discectomy and Fusion: A 2-Year Follow-up Study.

Authors:  James M Parrish; Nathaniel W Jenkins; Elliot D K Cha; Conor P Lynch; Cara E Geoghegan; Shruthi Mohan; Caroline N Jadczak; David P Matichak; Kern Singh
Journal:  Neurospine       Date:  2021-03-31

5.  Preoperative Neck Disability Severity Limits Extent of Postoperative Improvement Following Cervical Spine Procedures.

Authors:  Elliot D K Cha; Conor P Lynch; Shruthi Mohan; Cara E Geoghegan; Caroline N Jadczak; Kern Singh
Journal:  Neurospine       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.